ELP technology

Clinical-stage biopharmaceutical company PhaseBio recently filed for an initial public offering. The stock is expected to trade on the Nasdaq Global Market under the ticker symbol “PHAS.” The Company Founded in 2002, PhaseBio develops and researches treatments for orphan cardiopulmonary...